MedPath

Comparative study of Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade

Not Applicable
Not yet recruiting
Conditions
Respiratory
lung biopsy
Registration Number
PACTR201510001292136
Lead Sponsor
shahira el metainy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
60
Inclusion Criteria

ASA III&IV adult patients
over 60 years
undergo bronchoscopic lung biopsy

Exclusion Criteria

a difficult airway
known or suspected neuromuscular disorders significant renal dysfunction
patients receiving medication likely to interfere with rocuronium

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath